* Viemed Healthcare Inc VMD.OQ VMD.O is expected to show
a
rise in quarterly revenue when it reports results on November 6
for the period ending September 30 2024
* The Lafayette Louisiana-based company is expected to
report a
15.7% increase in revenue to $57.15 million from $49.4 million a
year ago, according to the mean estimate from 2 analysts, based
on LSEG data.
* LSEG's mean analyst estimate for Viemed Healthcare Inc is
for
earnings of 8 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Viemed
Healthcare
Inc is 12.50, above its last closing price of $8.61.
This summary was machine generated November 4 at 23:48 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)